학술논문
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Document Type
Artikel
Author
Source
Movement disorders : official journal of the Movement Disorder Society. 35(6):1046-1054
Subject
Language
English
English
English
ISSN
1531-8257